Monday, 31 July 2017

More than a third of U.S. adults prescribed opioids in 2015

(Reuters Health) - The United States needs to curb excessive opioid prescribing and improve access to pain management techniques, suggests a new government study.


Molecular profile hints at inflammatory processes in chronic fatigue

(Reuters Health) - - People with severe symptoms of chronic fatigue syndrome have a molecular signature in their blood made up of 17 immune system signaling molecules that are elevated, which may provide insight into how inflammation contributes to the mysterious condition.


Being born in U.S. ‘stroke belt’ tied to higher risk of dementia

(Reuters Health) - Hailing from the so-called stroke belt, a band of southern U.S. states with high stroke mortality rates, is associated with increased odds of developing dementia, even for people who relocate, a new study suggests.


Scientists develop scorpion 'milking machine' for disease research

CASABLANCA, Morocco (Reuters) - Extracting venom from scorpions can be a dangerous, but rewarding, task.


HIV-prevention pill can be taken as needed

Reuters Health - Men can safely take a pill that protects against the virus that causes AIDS when they need it, instead of every day, suggests a new study.


Insurers to fill Obamacare gaps in Ohio's individual market

(Reuters) - Five health insurance companies in Ohio, including Molina Healthcare Inc, have stepped up to sell health plans in 19 counties that would have been without Obamacare individual coverage in 2018, the state's insurance regulator said on Monday.


Express Scripts to cover Mylan's EpiPen, exclude rivals

NEW YORK (Reuters) - Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker Mylan Inc's versions of the EpiPen lifesaving allergy treatment over the allergy auto-injectors of other companies.


A million more web searches about suicide after ‘13 Reasons Why’

Reuters Health - Online searches related to suicide spiked right after Netflix released “13 Reasons Why,” a popular series about a teen girl who takes her own life, a U.S. study suggests.


U.S. FDA to review Teva and Celltrion's cancer biosimilar drug

JERUSALEM (Reuters) - Teva Pharmaceutical Industries and South Korea's Celltrion said on Monday the U.S. Food and Drug Administration has accepted for review a biologics application for a biosimilar drug to treat breast cancer.


Trump raises questions about healthcare actions on insurers

WASHINGTON (Reuters) - U.S. President Donald Trump on Monday raised questions about actions over healthcare that could affect the nation's heath insurance companies, one day after urging Republican senators to continue working to undo his predecessor's healthcare law.


J&J arthritis drug sirukumab raises safety concerns: FDA staff

(Reuters) - Staff reviewers for the U.S. Food and Drug Administration noted on Monday that there was a trend of increased death with Johnson & Johnson's experimental rheumatoid arthritis drug sirukumab compared with placebo.


Zimbabwe poultry farm hit again by avian flu outbreak

HARARE (Reuters) - A Zimbabwean poultry farm has reported a second outbreak of highly pathogenic H5N8 bird flu, two months after it first occurred, the state-owned Herald newspaper said on Monday.


Myanmar H1N1 swine flu death toll rises to 10

YANGON (Reuters) - Four more people have died in an outbreak of H1N1 influenza in Myanmar, a health official said on Monday, taking the death toll in the latest outbreak to 10 as the government stepped up public awareness campaigns about the swine flu virus.